Empowering people to assess their breast health by leveraging smart devices. That’s Debra Babalola and Shefali Bohra’s vision for Dotplot, as we increasingly embrace digital healthcare. Learn how they did it 👉 https://bit.ly/4eDBtuq #OnMyHorizon #BreastCancerAwarenessMonth #DigitalHealthcare
Cancer Research Horizons
Research Services
London, London 14,673 followers
We are Cancer Research UK's innovation arm, translating discovery into breakthrough treatments.
About us
Cancer Research Horizons is Cancer Research UK's innovation engine. We take scientific breakthroughs from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients. To date, we’ve played an instrumental role in forming over 60 spin-out companies and bringing 11 new cancer drugs to market, borne out of our pioneering research. We are the second biggest licensor of cancer research treatments globally and are part of Cancer Research UK – the world’s largest medical research charity. With exclusive rights to over £300m of world-class cancer research we’re a unique and powerful partner in the fight to beat cancer. We work closely with academia and industry to bridge the gap between research and the market, delivering maximum impact for patients. Every penny we make goes back into developing the next breakthroughs, helping bring forward the day when all cancer is conquered.
- Website
-
http://cancerresearchhorizons.com
External link for Cancer Research Horizons
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- London, London
- Founded
- 1902
- Specialties
- MedTech, Medical Devices, Drug Development, Clinical Trials, Biotech, Cancer research, Therapeutic Discovery Labs, Antibodies, Drug Discovery, Biotherapeutics, Small molecules, Biologics, Pharma, Functional Genomics, Translation, Commercialisation, entrepreneurialism, and Pharmaceuticals
Locations
-
Primary
2 Redman Pl, London
London, London E20 1JQ, GB
Employees at Cancer Research Horizons
Updates
-
Our #InnovationSummit24 agenda is now available! Discover pathways to innovation through sessions led by experts sharing knowledge and “out-of-the-box” approaches. See the full agenda here 👉 https://bit.ly/3NqLNdq Special thanks to our speakers. We’re looking forward to connecting with you all next month in Edinburgh! Simon Boulton, Genghis Lloyd-Harris, Susanti Susanti, Tiffany S. Ma, DPhil (PhD), Chris Walsh, PhD, Annelise Soulier, Jonathan Kwok, Ishani Malhotra, Tracy Weightman, Charlotte Waugh, Sânziana Foia, Joanne Edwards, CLAUDIA CAVALLUZZO, Duncan Martin, Andrea Taylor, Tom Bird, Neil Carragher, Valeria Pavet, Maria Lopalco-Michel, Stephen Shaw, Caroline Barelle, Tony Hickson, Charlie Gourley Alessia Errico PhD MBA, Phil Masterson, Clare Wareing Juliana Callaghan Abingworth, GambitBio, PT. PathGen Diagnostik Teknologi, Infinitopes, Intermediate Capital Group (ICG) Carcinotech Ltd, Cumulus Oncology, Edinburgh Innovations, Papcup, MI:RNA Diagnostics, The University of Edinburgh, Edinburgh Innovations, University of Dundee, Apollo Therapeutics
-
Our Annual review is out now! 📣 See our key milestones and discover the latest innovations, start-ups, and projects set to transform the oncology sector and improve the lives of those affected by cancer. Kudos to the researchers, partners and investors who are making these achievements a reality. Learn more 👉https://bit.ly/3zSM2ei And swipe below for a preview of our achievements in this past year. #OnMyHorizon #AnnualReview Iain Foulkes, Tony Hickson, Steve Wedge, Catherine Pickering, Rebecca Fitzgerald, Simon Boulton, Sânziana Foia, Rebecca Todd, Ishani Malhotra, Matt De Vries, Maike Heffner-de la Roche, Shefali Bohra, Debra Babalola, Bart Vanhaesebroeck, Genghis Lloyd-Harris, Jonathan Tobin, Christoph Lengauer, Carlos Garcia-Echeverria, Ph.D., Katharina Kreymborg, Karen Lackey, Sophia N Karagiannis, Sarah Mellor Kreftforeningen, KWF Kankerbestrijding, LifeArc Cancer Research UK (CRUK), Edinburgh Innovations, Papcup, Carcinotech Ltd, Cyted Health, CancerTools.org (CancerToolsOrg), The Francis Crick Institute, Dotplot, The Institute of Cancer Research, Astex Pharmaceuticals , iOnctura, NK:IO, Neobe Therapeutics, Cancer Research UK Scotland Institute, King's College London
-
Are γδ T cell therapies the next revolution in #cancer #immunotherapy? Congratulations to Cancer Research UK (CRUK) researchers Adrian Hayday et al. for this recent review that explores current trends that are reshaping the #CellTherapy sector in oncology. Read the review 👉 https://bit.ly/3U0oMBU #OnMyHorizon Julie Dechanet, Jamie Rossjohn, Bruno Silva-Santos, Priscilla Kelly Science Magazine, GammaDelta Therapeutics, The Francis Crick Institute Cancer Research UK Science and Innovation, CNRS, Monash University, Faculdade de Medicina da Universidade de Lisboa
-
Congratulations to NK:IO on finalising its seed round, which we were privileged to contribute to. We’re excited to see how the new CEO Richard Hopkins will drive NK:IO’s innovative natural killer cell therapies towards patient benefit. #OnMyHorizon
NK:IO progresses ovarian cancer natural killer therapy Imperial College London spin-out company NK:IO has completed a seed round to a total of £5.9 ($7.8) million. https://lnkd.in/eddNSxWi #OvarianCancer #Cancer #CellTherapy
-
🎤🔴 Going live this week 🌐📢 Our #CFurther colleagues Wendy Jacquemet-Ross and Tommy Rennison will be discussing with the #2024PEDS community how we can further engage with finance players to accelerate paediatric cancer breakthroughs. Register now: https://bit.ly/482rM6z CureSearch for Children's Cancer | LifeArc #OnMyHorizon #TranslationalResearch #PediatricOncology #RareCancer #InnovateForKids
-
What a successful, inspiring two days at #ELRIGDD24! 💡 It was great to connect with the drug discovery community, attend insightful talks, and share some of the ground-breaking research at the Target Discovery and Disease Modelling track, co-chaired by Rebecca Harris. Kudos to everyone who attended, to connections old and new, and to everyone who visited our booth. Thank you ELRIG UK for having us! Rachel Grimley, Ben Mackison, Sylvie Lachmann, Emily Wallace, Denice Chan, Nandana Shankar, Nikhil Gupta, PhD, Charlotte Walsh-Tripp, Leon Pang, Stuart Farrow, Nick Tribble, Kayvan Richter #OnMyHorizon #DrugDiscovery
-
💡 Could this T-cell engager offer safer cancer treatment without sacrificing efficacy? 📢 We’re partnering with NovalGen to take NVG-222 through the clinic at the Centre for Drug Development. NovalGen’s proprietary AutoRegulation technology is designed to mitigate toxicity and improve the therapeutic index of T-cell engagers. Read more 👉 https://lnkd.in/eWEbDSAD #OnMyHorizon #ClinicalTrials Amit Nathwani Lars Erwig Sophie Piper Ida Ricciardelli Stephen Nabarro
-
From personal experience to far-reaching impact. When Debra Babalola and Shefali Bohra found that many women shared their experience and struggled to find the right solution to assess their breast health, they decided to create one themselves. To mark #BreastCancerAwarenessMonth, we sat down with them to discuss the genesis and future of Dotplot. Read the interview 👉 https://bit.ly/4eDBtuq Imperial College London, Royal College of Art NIHR (National Institute for Health and Care Research), UK Research and Innovation, Imperial Enterprise Lab #OnMyHorizon #TranslationalResearch #WomenInSTEM #STEMCareers #WomenInSTEMEntrepreneurs
-
🎗️ 💛 Children’s cancer doesn’t stop at the end of #ChildhoodCancerAwareness month—it’s a year-round battle. #ICYMI, we launched #CFurther this month, dedicated to developing treatments specifically for #ChildhoodCancer. Read more in the STAT article by Jason Mast: https://lnkd.in/e5mJXCG8 Tony Hickson, David Jenkinson, LifeArc #OnMyHorizon #CancerResearch #PediatricOncology #RareCancer